Patient preferences for reducing bowel adverse events following prostate radiotherapy.
<h4>Background</h4>The Extended Prostate Cancer Index Composite (EPIC) instrument is a commonly used patient reported outcome (PRO) tool in prostate cancer clinical trials. Summary scores for EPIC subscales are calculated by averaging patient scores for attributes (e.g., side effects), i...
Saved in:
| Main Authors: | Mark V Mishra, Winter Maxwell Thayer, Ellen Janssen, Bradford Hoppe, Caitlin Eggleston, John F P Bridges |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2020-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0235616&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
by: Shiyi Wang, et al.
Published: (2025-02-01) -
Refining the interpretation of post-radiotherapy urinary and bowel outcomes in prostate cancer: A clinical perspective
by: Shengyi Chen, et al.
Published: (2025-07-01) -
Baseline atrial volume indices and major adverse cardiac events following thoracic radiotherapy
by: Edmund M. Qiao, et al.
Published: (2025-06-01) -
Patients prefer easy adverse event reporting: Observational study within clinical trial
by: Lauri Lukka, et al.
Published: (2025-05-01) -
Cardiovascular Adverse Events Associated with Prostate Cancer Treatment: A Disproportionality Analysis from the Food and Drug Administration Adverse Event Reporting System Database
by: Connor Frey
Published: (2024-11-01)